Cargando…
Harnessing CD8(+)CD28(−) Regulatory T Cells as a Tool to Treat Autoimmune Disease
T regulatory cell therapy presents a novel therapeutic strategy for patients with autoimmune diseases or who are undergoing transplantation. At present, the CD4(+) Treg population has been extensively characterized, as a result of defined phenotypic and functional readouts. In this review article, w...
Autores principales: | Ceeraz, Sabrina, Thompson, Charlotte R., Beatson, Richard, Choy, Ernest H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616472/ https://www.ncbi.nlm.nih.gov/pubmed/34831195 http://dx.doi.org/10.3390/cells10112973 |
Ejemplares similares
-
CD28(−) and CD28(low)CD8(+) Regulatory T Cells: Of Mice and Men
por: Vuddamalay, Yirajen, et al.
Publicado: (2017) -
CD28(−) Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status
por: Thompson, Charlotte, et al.
Publicado: (2020) -
Lenalidomide overcomes the immunosuppression of regulatory CD8(+)CD28(−) T-cells
por: Neuber, Brigitte, et al.
Publicado: (2017) -
CD28 engagement inhibits CD73-mediated regulatory activity of CD8(+) T cells
por: Lai, Yo-Ping, et al.
Publicado: (2021) -
Increased Percentage of CD8(+)CD28(−) Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis
por: Houston, Timothy W., et al.
Publicado: (2022)